Get the Stockscreener App
7.585
3.48%
0.255
Dariohealth Corp stock is traded at $7.585, with a volume of 5,321.
It is up +3.48% in the last 24 hours and up +16.16% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
See More
Previous Close:
$7.33
Open:
$7.24
24h Volume:
5,321
Relative Volume:
0.32
Market Cap:
$73.95M
Revenue:
$22.36M
Net Income/Loss:
$-33.61M
P/E Ratio:
-0.7882
EPS:
-9.6235
Net Cash Flow:
$-26.08M
1W Performance:
+3.90%
1M Performance:
+16.16%
6M Performance:
-35.28%
1Y Performance:
-12.98%
1-Day Range:
$7.24
$7.915
1-Week Range:
$6.75
$8.03
52-Week Range:
$5.8445
$17.74
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
7.585 | 72.93M | 22.36M | -33.61M | -26.08M | -9.6235 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report - simplywall.st
AI Chronic Care Platform Adds Fifth Fortune 50 Client, Lifts Margin to 62% - Streetwise Reports
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $8.00 at TD Cowen - MarketBeat
DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands - Streetwise Reports
DarioHealth (DRIO) Q2 2026 Earnings Call Transcript - AOL.com
DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ... - finance.yahoo.com
DarioHealth Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
DarioHealth Releases Q2 2026 Financial Results - AlphaStreet
DarioHealth (NASDAQ:DRIO) Issues Quarterly Earnings Results, Beats Estimates By $0.37 EPS - MarketBeat
DarioHealth Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue - Investing.com Australia
DarioHealth Corp reports results for the quarter ended June 30Earnings Summary - TradingView
DarioHealth Q2 Results: Adj. EPS beats estimates, sales miss - scanx.trade
DarioHealth Corp (DRIO) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
DarioHealth earnings beat by $0.40, revenue fell short of estimates - Investing.com
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
DarioHealth Reports Second Quarter 2026 Financial Results - PR Newswire
DarioHealth Corp. 2Q 2026: Revenue $5.18M, Net loss $7.92M — 10-Q Summary - TradingView
DarioHealth Corp. (DRIO) stock price, news, quote and history - Yahoo Finance Australia
DARIOHEALTH Q2 2026 Earnings Preview: Recent $DRIO Insider Trading, Hedge Fund Activity, and More - quiverquant.com
DarioHealth Corp expected to post a loss of $1.21 a shareEarnings Preview - tradingview.com
Digital Health Provider Launches Women's Health & Sleep Solutions - Streetwise Reports
AI Health Platform Expands Into Women's Health & Sleep With New Revenue Expected in Q4 - Streetwise Reports
DarioHealth Expands Platform with New Sleep and Women’s Health Solutions - Sleep Review
DarioHealth launches women’s health and sleep programs - Investing.com
DarioHealth launches women’s health and sleep programs By Investing.com - Investing.com South Africa
DarioHealth (DRIO) Projected to Release Quarterly Earnings on Tuesday - MarketBeat
Dario Expands Provider-Backed Cardiometabolic Platform with New - GuruFocus
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand - Barchart.com
New GLP-1 Platform Combines Doctor Prescriptions AI Coaching & Chronic Care - Streetwise Reports
DRIO|DarioHealth Corp|Price:7.210|Chg%:-0.060 - TradingKey
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026 - Morningstar
DarioHealth to release Q2 2026 earnings and hos... - Pluang
DarioHealth Corp (DRIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DarioHealth launches integrated GLP-1 program with clinical care By Investing.com - Investing.com Canada
Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience - TradingView
DarioHealth launches GLP-1 program with Fall 2026 commercial availability - scanx.trade
Form 4 DarioHealth Corp For: 28 July By Investing.com - Investing.com Nigeria
DarioHealth Corp (DRIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DarioHealth Corp (DRIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DarioHealth Corp. (DRIO) director buys 14,430 shares at $6.93 - Stock Titan
DarioHealth Corp (DRIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DarioHealth Corp (DRIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DarioHealth Corp (DRIO) Institutional Confidence - TradingKey
DarioHealth Corp (DRIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DRIO|DarioHealth Corp|Price:7.400|Chg%:-0.390 - TradingKey
DarioHealth Corp (DRIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
DarioHealth Corp (DRIO) Cash Flow - TradingKey
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last? - Yahoo Finance
Form 424B5 DarioHealth Corp For: 22 July By Investing.com - Investing.com South Africa
DarioHealth Announces $23.5 Million At-The-Market Direct Offering to Accelerate AI-Powered Healthcare Transformation 1 – Minichart - Minichart
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
6.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):